ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

31349 results sorted by trial registration date.
  • Investigating a novel method to predict weight outcome after a weight loss program

    Amongst people undertaking any weight loss program, there is considerable variation in the amount of weight lost. Many studies have attempted to predict the outcome of weight loss treatments from information about biological, behavioural and psychological factors collected from participants before the start of treatment, but it has been difficult to predict outcomes using current methods. In a previous study conducted in our research group, we examined a statistical method which appeared to be useful in predicting the outcome of a medically supervised very-low-energy diet program using participants’ baseline physical measurements and psychological characteristics. However, further research is required in order to create a tool which will be useful to patients and healthcare providers. The overall aim of this study is to create a statistical model which can accurately predict the result for a person about to start a weight loss program.

  • Oral sucrose for pain relief in children undergoing bladder catheterization.

    This study is to determine if oral sucrose is useful at reducing the pain and distress caused by bladder catheterisation in children. This is a common and important procedure, often required to diagnose urine infections in children, and currently there is no effective, practical methods proven to reduce the pain caused by this procedure.

  • Foot and lower limb complications following the use of extracorporeal membrane oxygenation (ECMO): The FECMO Study. A single centre retrospective observational study.

    What are the rates of foot and lower limb complications following the use of extracorporeal membrane oxygenation (ECMO) in a major Australian tertiary hospital? Our null hypothesis is that the incidence of foot and lower limb complications in patients undergoing ECMO treatment are not different to those reported in the general inpatient population.

  • Short term benefits of prehabilitation for Total Knee Joint Replacement (TKJR)

    A Total Knee Replacement (TKJR) is a common treatment for advanced osteoarthritis of the knee. Osteoarthritis is the wearing of the joint surfaces in the knee, over time becoming painful and severely limiting a person’s mobility. In a TKJR, worn joint surfaces of the knee are replaced with synthetic components, removing the source of pain and allowing a person to return to higher levels of function. However, the nature of the surgery means rehabilitation is required to allow the person to return to previous levels of activity. A TKJR is an elective procedure with a long wait list in the public hospital system. Individuals with private health insurance can avoid a long wait for surgery and have the procedure conducted in a private hospital, with insurance covering the majority of the costs for surgery. Private health insurance also commonly covers some of the costs associated with physiotherapy treatment and rehabilitation. Prehabilitation is the practice of exercising prior to a procedure to increase the strength and function of the body in order to speed up recovery after surgery. In the case of a TKJR, prehabilitation equates to increasing knee joint flexion, increasing strength in the muscles around the knee and improving general cardiovascular fitness. The ultimate aim of prehabilitation is to speed the recovery after surgery through the strengthening of major muscles groups beforehand. It is current practice at St Vincent's Private, Kew, that patients undergoing a TKJR are given the option to undertake prehabilitation or not. This research aims to determine whether prehabilitation in a private hospital setting improves short -term outcomes after TKJR.

  • Comparison of the effect of an anti-platelet intervention with Ticagrelor versus placebo on participants with asymptomatic elevations in troponin T

    Within a 1:1 randomised trial, this study will compare the effect of an antiplatelet approach with Ticagrelor versus placebo on 3, 6, and 12 month high-sensitivity troponin levels. It will also explore the frequency of late cardiovascular events, and the impact of P2Y12 platelet inhibition versus placebo on late cardiovascular events, among patients with elevations in high-sensitivity troponin not attributable to other acute clinical diagnoses.

  • Phase I trial of oral triheptanoin add-on treatment for children with medically refractory epilepsy

    We established that triheptanoin (triglyceride of heptanoate), a stable, edible tasteless oil that has been used in the clinic in patients with metabolic disorders, is an anticonvulsant in four mouse seizure models. This Phase I clinical trial aims to establish the feasibility, safety and tolerability of triheptanoin as add-on treatment in children with treatment-resistant epilepsy, and obtain indications for its efficacy against medically refractory seizures. We propose to initiate a pilot phase I clinical trial of 50 children (3-18 yr of age) with treatment-resistant epilepsy at the Royal and Mater Children’s Hospitals in Brisbane. Eligible patients without contraindications to triheptanoin will count seizures during a baseline period of two months. Subjects with more than two seizures per fortnight will be enrolled and receive slowly increasing doses of triheptanoin (max 35% of caloric intake) during meals until the maximum tolerable dose is reached. All patients will be counselled and monitored by a dietitian before, during and after the treatment to ensure that they receive adequate nutrition. This treatment would be ideal for patients with epilepsy in the developed and developing world, because: 1) triheptanoin does not require refrigeration and is straightforward to add to meals and 2) it is not expected to change metabolism of other drugs and require “drug monitoring” nor to have significant side effects.

  • Narrow band ultraviolet-B (UVB) light for patients with Clinically Isolated Syndrome

    People who have experienced for the first time an episode of inflammation within the brain, spinal cord or optic nerves (called a first demyelinating event) are at risk of developing Multiple Sclerosis. In this study, we will test whether a course of narrow band UVB phototherapy decreases their risk of developing Multiple Sclerosis.

  • A Cluster Randomized Controlled Trial of a School-based Physical Activity Intervention in At-risk Communities: The Activity and Motivation in Physical Education (AMPED) Project

    Funded by the Australian Research Council, this study will test the effect of a professional development program targeting physical education teachers that is designed to increase students’ opportunities for physical activity during physical education lessons and to enhance their motivation towards physical activity. This research is important because many Australian youth do not participate in sufficient physical activity and there is a large decline in physical activity associated with adolescence. As a result, there is an urgent need to develop strategies to engage adolescents in physical activity. If adolescent physical activity levels can be increased, a variety of benefits are expected, including engagement during academic classes, greater self-concept, and better overall well-being.

  • Critical Evaluation of a Targeted Point of Care (POC) ROTEM (Registered Trademark) and Multiplate (Registered Trademark) Guided Coagulation and Haemostasis Management Programme in Cardiac Surgical Patients

    There is an increasing body of evidence that the adoption of point of care (POC) guided coagulation and haemostatic management algorithms in the cardiac surgical patient population results in improved outcomes. We aim to critically evaluate our POC programme at the Gold Coast University Hospital (GCUH). In addition, we aim to evaluate the prognostic importance of baseline and perioperative humeral factors relating to haem catabolism (bilirubin/carboxy haemoglobin) in modulating haemostatic function and predicting post-operative outcomes in patients undergoing cardiac surgery

  • A Study to Compare Loperimide to Placebo for the Prevention of Excess Fluid Losses From the Stoma in Patients with New Loop Ileostomy.

    One of the commonest complications of an ileostomy is the potential loss of a large amount of fluids and salts from the ileostomy, and this is called a high output ileostomy. A high output ileostomy can cause a person to become dehydrated and when the losses are large enough, it can lead to kidney failure, and re-presentation to hospital, with admission to hospital with long hospital stay The purpose of this study is to see if large ileostomy output can be prevented from occurring, rather than waiting for it to happen and then treating it.

Tags:
  • Finding clinical trials